Search
for
Sort by
Research 31–60 of 1000+
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Repurposing of approved cardiovascular drugs
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas
- Are South African Wild Foods the Answer to Rising Rates of Cardiovascular Disease?
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Effects of 5-alpha reductase inhibitors
- The rationale for physiological testosterone replacement in women
- Endocrinology of Transgender Medicine
- Hormonal contraceptives: pharmacology tailored to women's health
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Testosterone therapy for transgender men
- NEW PROPRIETARY BRANDS: Cephalexin
- NEW FORMULATIONS: Sodium cromoglycate
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Potential adverse effects of long-term testosterone therapy
- Topical Minoxidil
- Management of polycystic ovarian syndrome through Homoeopathy: A Case Report
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders